RENAISSANCE TECHNOLOGIES LLC

Position in CDXS — Codexis, Inc.

CIK 1037389 NEW YORK, NY

Position in CDXS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$323,934

-$878,166 QoQ

Shares Held

198,733

-73.1% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,246,114,299 across 329 Biotechnology names. CDXS ranks #238 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$323,934	198,733	-73.1%	Shares	Sole	2026-05-14
2025-12-31	$1,202,100	737,485	+137.5%	Shares	Sole	2026-02-12
2025-09-30	$757,585	310,486	-58.9%	Shares	Sole	2025-11-13
2025-06-30	$1,843,385	755,486	+16.1%	Shares	Sole	2025-08-13
2025-03-31	$1,750,614	650,786	+78.8%	Shares	Sole	2025-05-14
2024-03-31	$1,270	363,986	+39.8%	Shares	Sole	2024-05-13
2023-09-30	$492	260,286	-74.5%	Shares	Sole	2023-11-14
2023-06-30	$2,860	1,021,588	+31.3%	Shares	Sole	2023-08-11
2023-03-31	$3,221	778,100	+136.5%	Shares	Sole	2023-05-12
2022-12-31	$1,533	329,000	+112.3%	Shares	Sole	2023-02-13
2022-09-30	$939,251	154,992	+742.3%	Shares	Sole	2022-11-14
2021-06-30	$416,944	18,400	-42.9%	Shares	Sole	2021-08-13
2020-06-30	$367,080	32,200	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.